Ontology highlight
ABSTRACT:
OTHER RELATED OMICS DATASETS IN: PRJNA185822PRJNA241314PRJNA185821PRJNA185826PRJNA185825PRJNA185824PRJNA185823PRJNA185827PRJNA213744PRJNA213380PRJNA214321
PROVIDER: EGAO00000000036 | EGA |
REPOSITORIES: EGA
Cancer cell 20140301 3
Smoothened (SMO) inhibitors recently entered clinical trials for sonic-hedgehog-driven medulloblastoma (SHH-MB). Clinical response is highly variable. To understand the mechanism(s) of primary resistance and identify pathways cooperating with aberrant SHH signaling, we sequenced and profiled a large cohort of SHH-MBs (n = 133). SHH pathway mutations involved PTCH1 (across all age groups), SUFU (infants, including germline), and SMO (adults). Children >3 years old harbored an excess of downstream ...[more]